0001192482-18-000047.txt : 20180122 0001192482-18-000047.hdr.sgml : 20180122 20180122170017 ACCESSION NUMBER: 0001192482-18-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180118 FILED AS OF DATE: 20180122 DATE AS OF CHANGE: 20180122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celano Michael CENTRAL INDEX KEY: 0001377582 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 18540391 MAIL ADDRESS: STREET 1: 220 EAST FIRST STREET CITY: BETHLEHEM STATE: PA ZIP: 18015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-01-18 0001588972 Recro Pharma, Inc. REPH 0001377582 Celano Michael C/O RECRO PHARMA, INC. 490 LAPP ROAD MALVERN PA 19355 0 1 0 0 Chief Operating Officer Common Stock 2018-01-18 4 M 0 6400 A 30495 D Common Stock 2018-01-18 4 F 0 2020 8.89 D 28475 D Restricted Stock Units 2018-01-18 4 M 0 6400 0 D Common Stock 6400 19200 D Restricted stock units convert into common stock on a one-for-one basis. On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. /s/ Ryan D. Lake, Attorney-in-fact 2018-01-22